Hypogonadism, Erectile Dysfunction, and Type 2 Diabetes Mellitus: What the Clinician Needs to Know

References

• . Bhasin S, Cunningham GR, Hayes FJ, ; Endocrine Society. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(6):2536–2559
   PubMed Web of Science ®Google Scholar
• . Dandona P, Rosenberg MT. A practical guide to male hypogonadism in the primary care setting. Int J Clin Pract. 2010;64(6):682–696
   PubMed Web of Science ®Google Scholar
• . Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ; American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients—2002 update. Endocr Pract. 2002;8(6):440–456
   PubMedGoogle Scholar
• . Dhindsa S, Prabhakar S, Sethi M, Bandyopadhyay A, Chaudhuri A, Dandona P. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004;89(11):5462–5468
   PubMed Web of Science ®Google Scholar
• . NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993;270(1):83–90
   PubMed Web of Science ®Google Scholar
• . Lue TF. Erectile dysfunction. N Engl J Med. 2000;342(24):1802–1813
   PubMed Web of Science ®Google Scholar
• . Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33( suppl 1):S62–S69
   PubMedGoogle Scholar
• . Wu FC, Tajar A, Beynon JM, ; EMAS Group. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010;363(2):123–135
   PubMed Web of Science ®Google Scholar
• . Araujo AB, O'Donnell AB, Brambilla DJ, . Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004;89(12):5920–5926
   PubMed Web of Science ®Google Scholar
• . Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762–769
   PubMed Web of Science ®Google Scholar
• . Feldman HA, Longcope C, Derby CA, . Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87(2):589–598
   PubMed Web of Science ®Google Scholar
• . Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR; Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001;86(2):724–731
   PubMed Web of Science ®Google Scholar
• . Litman HJ, Bhasin S, Link CL, Araujo AB, McKinlay JB. Serum androgen levels in black, Hispanic, and white men. J Clin Endocrinol Metab. 2006;91(11):4326–4334
   PubMed Web of Science ®Google Scholar
• . Araujo AB, Esche GR, Kupelian V, . Prevalence of symptomatic androgen deficiency in men. J Clin Endocrinol Metab. 2007;92(11):4241–4247
   PubMed Web of Science ®Google Scholar
• . Liu CC, Wu WJ, Lee YC, . The prevalence of and risk factors for androgen deficiency in aging Taiwanese men. J Sex Med. 2009;6(4):936–946
   PubMed Web of Science ®Google Scholar
• . Grossmann M, Thomas MC, Panagiotopoulos S, . Low testosterone levels are common and associated with insulin resistance in men with diabetes. J Clin Endocrinol Metab. 2008;93(5):1834–1840
   PubMed Web of Science ®Google Scholar
• . Chandel A, Dhindsa S, Topiwala S, Chaudhuri A, Dandona P. Testosterone concentration in young patients with diabetes. Diabetes Care. 2008;31(10):2013–2017
   PubMed Web of Science ®Google Scholar
• . Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correlations with bioavailable testosterone and visceral adiposity. Diabetes Care. 2007;30(4):911–917
   PubMed Web of Science ®Google Scholar
• . Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295(11):1288–1299
   PubMed Web of Science ®Google Scholar
• . Colangelo LA, Ouyang P, Liu K, . Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multiethnic study of atherosclerosis. Diabetes Care. 2009;32(6):1049–1051
   PubMed Web of Science ®Google Scholar
• . Dhindsa S, Miller MG, McWhirter CL, . Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33(6):1186–1192
   PubMed Web of Science ®Google Scholar
• . Yeap BB, Almeida OP, Hyde Z, . Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study. Clin Endocrinol (Oxf). 2009;70(3):455–163
   PubMed Web of Science ®Google Scholar
• . Stellato RK, Feldman HA, Hamdy O, Horton ES, McKinlay JB. Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care. 2000;23(4):490–494
   PubMed Web of Science ®Google Scholar
• . Laaksonen DE, Niskanen L, Punnonen K, . Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care. 2004;27(5):1036–1041
   PubMed Web of Science ®Google Scholar
• . Oh JY, Barrett-Connor E, Wedick NM, Wingard DL; Rancho Bernardo Study. Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study. Diabetes Care. 2002;25(1):55–60
   PubMed Web of Science ®Google Scholar
• . Lakshman KM, Bhasin S, Araujo AB. Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men. J Gerontol A Biol Sci Med Sci. 2010;65(5):503–509
   PubMed Web of Science ®Google Scholar
• . Guay AT, Spark RF, Bansal S, ; American Association of Clinical Endocrinologists Male Sexual Dysfunction Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem—2003 update. Endocr Pract. 2003;9(1):77–95
   PubMedGoogle Scholar
• . Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120(2):151–157
   PubMed Web of Science ®Google Scholar
• . Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000;163(2):460–463
   PubMed Web of Science ®Google Scholar
• . Kupelian V, Shabsigh R, Travison TG, Page ST, Araujo AB, McKinlay JB. Is there a relationship between sex hormones and erectile dysfunction? Results from the Massachusetts Male Aging Study. J Urol. 2006;176(6 pt 1):2584–2588
   PubMed Web of Science ®Google Scholar
• . Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care. 2002;25(8):1458–1463
   PubMed Web of Science ®Google Scholar
• . Lu CC, Jiann BP, Sun CC, Lam HC, Chu CH, Lee JK. Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes. J Sex Med. 2009;6(6):1719–1728
   PubMed Web of Science ®Google Scholar
• . Awad H, Salem A, Gadalla A, El Wafa NA, Mohamed OA. Erectile function in men with diabetes type 2: correlation with glycemic control. Int J Impot Res. 2010;22(1):36–39
   PubMed Web of Science ®Google Scholar
• . Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K. Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res. 2010;22(3):204–209
   PubMed Web of Science ®Google Scholar
• . Zheng H, Fan W, Li G, Tam T. Predictors for erectile dysfunction among diabetics. Diabetes Res Clin Pract. 2006;71(3):313–319
   PubMed Web of Science ®Google Scholar
• . Inman BA, Sauver JL, Jacobson DJ, . A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Mayo Clin Proc. 2009;84(2):108–113
   PubMed Web of Science ®Google Scholar
• . Ma RC, So WY, Yang X, . Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol. 2008;51(21):2045–2050
   PubMed Web of Science ®Google Scholar
• . Tamler R. Diabetes, obesity, and erectile dysfunction. Gend Med. 2009;6( suppl 1):4–16
   PubMedGoogle Scholar
• . Wang C, Nieschlag E, Swerdloff R, ; International Society of Andrology (ISA); International Society for the Study of Aging Male (ISSAM); European Association of Urology (EAU); European Academy of Andrology (EAA); American Society of Andrology (ASA). Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. J Androl. 2009;30(1):1–9
   PubMedGoogle Scholar
• . Imai A, Yamamoto H, Hatakeyama S, . Risk factors for erectile dysfunction in healthy Japanese men. Int J Androl. 2010;33(4):569–573
   PubMedGoogle Scholar
• . Corona G, Mannucci E, Petrone L, . Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res. 2006;18(2):190–197
   PubMed Web of Science ®Google Scholar
• . Corona G, Mannucci E, Forti G, Maggi M. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? Int J Androl. 2009;32(5):431–441
   PubMedGoogle Scholar
• . El-Sakka AI, Sayed HM, Tayeb KA. Type 2 diabetes-associated androgen alteration in patients with erectile dysfunction. Int J Androl. 2008;31(6):602–608
   PubMedGoogle Scholar
• . Somani B, Khan S, Donat R. Screening for metabolic syndrome and testosterone deficiency in patients with erectile dysfunction: results from the first UK prospective study [published online ahead of print January 11, 2010]. BJU Int.
   Google Scholar
• . Corona G, Mannucci E, Petrone L, . NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med. 2007;4(4 pt 1):1038–1045
   PubMed Web of Science ®Google Scholar
• . Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl. 2009;30(1):10–22
   PubMed Web of Science ®Google Scholar
• . Bojesen A, Host C, Gravholt CH. Klinefelter's syndrome, type 2 diabetes and the metabolic syndrome: the impact of body composition. Mol Hum Reprod. 2010;16(6):396–401
   PubMed Web of Science ®Google Scholar
• . Saylor PJ, Smith MR. Metabolic complications of androgen deprivation therapy for prostate cancer. J Urol. 2009;181(5):1998–2006
   PubMed Web of Science ®Google Scholar
• . Shabsigh R, Arver S, Channer KS. The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. Int J Clin Pract. 2008;62(5):791–798
   PubMed Web of Science ®Google Scholar
• . Schwandt A, Garcia JA. Complications of androgen deprivation therapy in prostate cancer. Curr Opin Urol. 2009;19(3):322–326
   PubMed Web of Science ®Google Scholar
• . Tripathy D, Dhindsa S, Garg R, Khaishagi A, Syed T, Dandona P. Hypogonadotropic hypogonadism in erectile dysfunction associated with type 2 diabetes mellitus: a common defect? Metab Syndr Relat Disord. 2003;1(1):75–80
   PubMed Web of Science ®Google Scholar
• . Dandona P, Dhindsa S, Chandel A, Chaudhuri A. Hypogonadotropic hypogonadism in men with type 2 diabetes. Postgrad Med. 2009;121(3):45–51
   PubMed Web of Science ®Google Scholar
• . Deslypere JP, Verdonck L, Vermeulen A. Fat tissue: a steroid reservoir and site of steroid metabolism. J Clin Endocrinol Metab. 1985;61(3):564–570
   PubMed Web of Science ®Google Scholar
• . Tsai EC, Boyko EJ, Leonetti DL, Fujimoto WY. Low serum testosterone level as a predictor of increased visceral fat in Japanese-American men. Int J Obes Relat Metab Disord. 2000;24(4):485–491
   PubMed Web of Science ®Google Scholar
• . Kupelian V, Page ST, Araujo AB, Travison TG, Bremner WJ, McKinlay JB. Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006;91(3):843–850
   PubMed Web of Science ®Google Scholar
• . Akishita M, Hashimoto M, Ohike Y, . Low testosterone level is an independent determinant of endothelial dysfunction in men. Hypertens Res. 2007;30(11):1029–1034
   PubMed Web of Science ®Google Scholar
• . Knoblovits P, Costanzo PR, Valzacchi GJ, . Erectile dysfunction, obesity, insulin resistance, and their relationship with testosterone levels in eugonadal patients in an andrology clinic setting. J Androl. 2010;31(3):263–270
   PubMedGoogle Scholar
• . Vlachopoulos C, Aznaouridis K, Ioakeimidis N, . Unfavourable endothelial and inflammatory state in erectile dysfunction patients with or without coronary artery disease. Eur Heart J. 2006;27(22):2640–2648
   PubMed Web of Science ®Google Scholar
• . Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH. The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2007;156(5):595–602
   PubMed Web of Science ®Google Scholar
• . Bhatia V, Chaudhuri A, Tomar R, Dhindsa S, Ghanim H, Dandona P. Low testosterone and high C-reactive protein concentrations predict low hematocrit in type 2 diabetes. Diabetes Care. 2006;29(10):2289–2294
   PubMed Web of Science ®Google Scholar
• . Esposito K, Giugliano F, Di Palo C, . Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004;291(24):2978–2984
   PubMed Web of Science ®Google Scholar
• . Watanobe H, Hayakawa Y. Hypothalamic interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, mediate the endotoxin-induced suppression of the reproductive axis in rats. Endocrinology. 2003;144(11):4868–4875
   PubMed Web of Science ®Google Scholar
• . Wu XY, Mao JF, Lu SY, Zhang Q, Shi YF. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients. Chin Med J (Engl). 2009;122(23):2846–2850
   PubMed Web of Science ®Google Scholar
• . Pitteloud N, Mootha VK, Dwyer AA, . Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care. 2005;28(7):1636–1642
   PubMed Web of Science ®Google Scholar
• . Yeap BB, Chubb SA, Hyde Z, . Lower serum testosterone is independently associated with insulin resistance in non-diabetic older men: the Health In Men Study. Eur J Endocrinol. 2009;161(4):591–598
   PubMed Web of Science ®Google Scholar
• . Brüning JC, Gautam D, Burks DJ, . Role of brain insulin receptor in control of body weight and reproduction. Science. 2000;289(5487):2122–2125
   PubMed Web of Science ®Google Scholar
• . Dandona P, Dhindsa S, Chaudhuri A, Bhatia V, Topiwala S, Mohanty P. Hypogonadotrophic hypogonadism in type 2 diabetes, obesity and the metabolic syndrome. Curr Mol Med. 2008;8(8):816–828
   PubMedGoogle Scholar
• . Ponikowska B, Jankowska EA, Maj J, . Gonadal and adrenal androgen deficiencies as independent predictors of increased cardiovascular mortality in men with type II diabetes mellitus and stable coronary artery disease. Int J Cardiol. 2010;143(3):343–348
   PubMed Web of Science ®Google Scholar
• . Vesper HW, Botelho JC. Standardization of testosterone measurements in humans. J Steroid Biochem Mol Biol. 2010;121(3–5):513–519
   PubMed Web of Science ®Google Scholar
• . Travison TG, Morley JE, Araujo AB, O'Donnell AB, McKinlay JB. The relationship between libido and testosterone levels in aging men. J Clin Endocrinol Metab. 2006;91(7):2509–2513
   PubMed Web of Science ®Google Scholar
• . Wespes E, Amar E, Hatzichristou D, . EAU Guidelines on erectile dysfunction: an update. Eur Urol. 2006;49(5):806–815
   PubMed Web of Science ®Google Scholar
• . Shiri R, Koskimäki J, Häkkinen J, Auvinen A, Tammela TL, Hakama M. Cardiovascular drug use and the incidence of erectile dysfunction. Int J Impot Res. 2007;19(2):208–212
   PubMed Web of Science ®Google Scholar
• . Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res. 2005;17(4):307–319
   PubMed Web of Science ®Google Scholar
• . Grant PS, Lipscomb D. How often do we ask about erectile dysfunction in the diabetes review clinic? Development of a neuropathy screening tool. Acta Diabetol. 2009;46(4):285–290
   PubMed Web of Science ®Google Scholar
• . Esposito K, Marfella R, Ciotola M, . Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA. 2004;292(12):1440–1446
   PubMed Web of Science ®Google Scholar
• . Giugliano F, Maiorino MI, Bellastella G, . Adherence to Mediterranean diet and erectile dysfunction in men with type 2 diabetes. J Sex Med. 2010;7(5):1911–1917
   PubMed Web of Science ®Google Scholar
• . Kaukua J, Pekkarinen T, Sane T, Mustajoki P. Sex hormones and sexual function in obese men losing weight. Obes Res. 2003;11(6):689–694
   PubMedGoogle Scholar
• . Khoo J, Piantadosi C, Worthley S, Wittert GA. Effects of a low-energy diet on sexual function and lower urinary tract symptoms in obese men. Int J Obes (Lond). 2010;34(9):1396–1403
   PubMed Web of Science ®Google Scholar
• . Hammoud A, Gibson M, Hunt SC, . Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men. J Clin Endocrinol Metab. 2009;94(4):1329–1332
   PubMed Web of Science ®Google Scholar
• . Omana JJ, Tamler R, Strohmayer E, Herron D, Kini S. Sex hormone levels in men undergoing bariatric surgery. J Am Coll Surg. 2009;209( 3 suppl):S22–S23
   Web of Science ®Google Scholar
• . Globerman H, Shen-Orr Z, Karnieli E, Aloni Y, Charuzi I. Inhibin B in men with severe obesity and after weight reduction following gastroplasty. Endocr Res. 2005;31(1):17–26
   PubMed Web of Science ®Google Scholar
• . Grossmann M, Gianatti EJ, Zajac JD. Testosterone and type 2 diabetes. Curr Opin Endocrinol Diabetes Obes. 2010;17(3):247–256
   PubMedGoogle Scholar
• . Miner M, Canty DJ, Shabsigh R. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices. Postgrad Med. 2008;120(3)130–153
   PubMed Web of Science ®Google Scholar
• . Kapoor D, Goodwin E, Channer KS, Jones TH. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. Eur J Endocrinol. 2006;154(6):899–906
   PubMed Web of Science ®Google Scholar
• . Aversa A, Bruzziches R, Francomano D, . Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study [published online ahead of print July 14, 2010]. J Sex Med.
   Google Scholar
• . Kalinchenko S, Zemlyanoy A, Gooren LJ. Improvement of the diabetic foot upon testosterone administration to hypogonadal men with peripheral arterial disease. Report of three cases. Cardiovasc Diabetol. 2009;8:19
   PubMed Web of Science ®Google Scholar
• . Gopal RA, Bothra N, Acharya SV, . Treatment of hypogonadism with testosterone in type 2 diabetes mellitus. Endocr Pract. 2010;16(4):1–20
   Web of Science ®Google Scholar
• . Isidori AM, Giannetta E, Greco EA, . Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005;63(3):280–293
   PubMed Web of Science ®Google Scholar
• . Yialamas MA, Dwyer AA, Hanley E, Lee H, Pitteloud N, Hayes FJ. Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2007;92(11):4254–4259
   PubMed Web of Science ®Google Scholar
• . Isidori AM, Giannetta E, Gianfrilli D, . Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf). 2005;63(4):381–394
   PubMed Web of Science ®Google Scholar
• . Park K, Ku JH, Kim SW, Paick JS. Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction. BJU Int. 2005;95(3):366–370
   PubMed Web of Science ®Google Scholar
• . Corona G, Maggi M. The role of testosterone in erectile dysfunction. Nat Rev Urol. 2010;7(1):46–56
   PubMed Web of Science ®Google Scholar
• . Shabsigh R, Crawford ED, Nehra A, Slawin KM. Testosterone therapy in hypogonadal men and potential prostate cancer risk: a systematic review. Int J Impot Res. 2009;21(1):9–23
   PubMed Web of Science ®Google Scholar
• . Basaria S, Coviello AD, Travison TG, . Adverse events associated with testosterone administration. N Engl J Med. 2010;363(2):109–122
   PubMed Web of Science ®Google Scholar
• . Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl. 2009;30(5):477–494
   PubMedGoogle Scholar
• . Caminiti G, Volterrani M, Iellamo F, . Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol. 2009;54(10):919–927
   PubMed Web of Science ®Google Scholar
• . Shabsigh A, Kang Y, Shabsign R, . Clomiphene citrate effects on testosterone/estrogen ratio in male hypogonadism. J Sex Med. 2005;2(5):716–721
   PubMed Web of Science ®Google Scholar
• . Kaminetsky J, Hemani ML. Clomiphene citrate and enclomiphene for the treatment of hypogonadal androgen deficiency. Expert Opin Investig Drugs. 2009;18(12):1947–1955
   PubMed Web of Science ®Google Scholar
• . Guay AT, Jacobson J, Perez JB, . Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit? Int J Impot Res. 2003;5(3):156–165
   Google Scholar
• . Taylor F, Levine L. Clomiphene citrate and testosterone gel replacement therapy for male hypogonadism: efficacy and treatment cost. J Sex Med. 2010;7(1 pt 1):269–276
   PubMed Web of Science ®Google Scholar
• . Bakircioglu ME, Erden HF, Ciray HN, Bayazit N, Bahçeci M. Gonadotrophin therapy in combination with ICSI in men with hypogonadotrophic hypogonadism. Reprod Biomed Online. 2007;15(2):156–160
   PubMed Web of Science ®Google Scholar
• . Hall SA, Araujo AB, Esche GR, . Treatment of symptomatic androgen deficiency: results from the Boston Area Community Health Survey. Arch Intern Med. 2008;168(10):1070–1076
   PubMedGoogle Scholar
• . Kaplan SA, Meehan AG, Shah A. The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol. 2006;176(4 pt 1):1524–1527
   PubMed Web of Science ®Google Scholar
• . Yeap BB, Hyde Z, Almeida OP, . Lower testosterone levels predict incident stroke and transient ischemic attack in older men. J Clin Endocrinol Metab. 2009;94(7):2353–2359
   PubMed Web of Science ®Google Scholar
• . Maggio M, Basaria S. Welcoming low testosterone as a cardiovascular risk factor. Int J Impot Res. 2009;21(4):261–264
   PubMed Web of Science ®Google Scholar
• . Pecori Giraldi F, Toja PM, Filippini B, . Increased prevalence of prolonged QT interval in males with primary or secondary hypogonadism: a pilot study. Int J Androl. 2010;33(1):e132–e138
   Google Scholar
• . Shores MM, Matsumoto AM, Sloan KL, Kivlahan DR. Low serum testosterone and mortality in male veterans. Arch Intern Med. 2006;166(15):1660–1665
   PubMedGoogle Scholar
• . Shores MM, Kivlahan DR, Sadak TI, Li EJ, Matsumoto AM. A randomized, double-blind, placebo-controlled study of testosterone treatment in hypogonadal older men with subthreshold depression (dysthymia or minor depression). J Clin Psychiatry. 2009;70(7):1009–1016
   PubMed Web of Science ®Google Scholar
• . Giltay EJ, Tishova YA, Mskhalaya GJ, Gooren LJ, Saad F, Kalinchenko SY. Effects of testosterone supplementation on depressive symptoms and sexual dysfunction in hypogonadal men with the metabolic syndrome. J Sex Med. 2010;7(7):2572–2582
   PubMed Web of Science ®Google Scholar
• . Zarrouf FA, Artz S, Griffith J, Sirbu C, Kommor M. Testosterone and depression: systematic review and meta-analysis. J Psychiatr Pract. 2009;15(4):289–305
   PubMed Web of Science ®Google Scholar
• . Emmelot-Vonk MH, Verhaar HJ, Nakhai Pour HR, . Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial. JAMA. 2008;299(1):39–52
   PubMed Web of Science ®Google Scholar
• . Lu PH, Masterman DA, Mulnard R, . Effects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly men. Arch Neurol. 2006;63(2):177–185
   PubMedGoogle Scholar
• . Moffat SD, Zonderman AB, Metter EJ, . Free testosterone and risk for Alzheimer disease in older men. Neurology. 2004;62(2):188–193
   PubMed Web of Science ®Google Scholar
• . Fink HA, Ewing SK, Ensrud KE, . Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab. 2006;91(10):3908–3915
   PubMed Web of Science ®Google Scholar
• . Dhindsa S, Bhatia V, Dhindsa G, Chaudhuri A, Gollapudi GM, Dandona P. The effects of hypogonadism on body composition and bone mineral density in type 2 diabetic patients. Diabetes Care. 2007;30(7):1860–1861
   PubMed Web of Science ®Google Scholar
• . Tracz MJ, Sideras K, Boloña ER, . Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab. 2006;91(6):2011–2016
   PubMed Web of Science ®Google Scholar
• . Meier C, Nguyen TV, Handelsman DJ, . Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. Arch Intern Med. 2008;168(1):47–54
   PubMedGoogle Scholar
• . Szulc P, Claustrat B, Marchand F, Delmas PD. Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. J Clin Endocrinol Metab. 2003;88(11):5240–5247
   PubMed Web of Science ®Google Scholar
• . Krasnoff JB, Basaria S, Pencina MJ, . Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study. J Clin Endocrinol Metab. 2010;95(6):2790–2799
   PubMed Web of Science ®Google Scholar
• . Hyde Z, Flicker L, Osvaldo AP, . Low free testosterone predicts frailty in older men: the Health In Men study. J Clin Endocrinol Metab. 2010;95(7):3165–3172
   PubMed Web of Science ®Google Scholar
• . Grossmann M, Panagiotopolous S, Sharpe K, . Low testosterone and anaemia in men with type 2 diabetes. Clin Endocrinol (Oxf). 2009;70(4):547–553
   PubMed Web of Science ®Google Scholar